Skip to main content
Midas Edge

PALATIN TECHNOLOGIES INC

For the period ended Jun 30, 2026. Filed Sep 28, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Sep 28, 2026

PTN$6.89-4.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 15. Exhibits and Financial Statement Schedules

Item 15. Exhibit and Financial Statement Schedules.

(a) Documents filed as part of the report:

1.Financial statements: The following consolidated financial statements are filed as a part of this report under Item 8 – Financial Statements and Supplementary Data:

— Report of Independent Registered Public Accounting Firm

— Consolidated Balance Sheets

— Consolidated Statements of Operations

— Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders’ Equity

— Consolidated Statements of Cash Flows

— Notes to Consolidated Financial Statements

  1. Financial statement schedules: None.
3.List of Exhibits

The following exhibits are incorporated by reference or filed as part of this report:

Exhibit Number · Description · Filed Herewith · Form · Filing Date · SEC File No.
3.1 · Restated Certificate of Incorporation of Palatin Technologies, Inc., as amended. · X
3.2Amended and Restated Bylaws of Palatin Technologies, Inc.8-KSeptember 17, 2021001-15543
3.3Certificate of Decrease of Series A Convertible Preferred Stock10-QMay 16, 2022001-15543
3.4Certificate of Designation of the Rights, Powers, Preferences, Privileges, and Restrictions, of the Series D Convertible Preferred Stock of Palatin Technologies, Inc.8-KJune 13, 2025001-15443
3.5Certificate of Amendment to Restated Certificate of Incorporation, filed with the Delaware Secretary of State on August 6, 2025.8-KAugust 8, 2025001-15543
4.1Form of Series I Common Stock Purchase Warrant.8-KJune 13, 2025001-15543
4.2Form of Series F Common Warrant.8-KMay 8, 2025001-15543
4.3Form of Series G Common Warrant.8-KMay 8, 2025001-15543
4.4Form of Series H Common Warrant.8-KMay 8, 2025001-15543
4.5Form of Pre-Funded Warrant.S-1March 31, 2025333-286280
4.6Form of Common Warrant.S-1March 31, 2025333-286280
4.7Form of Pre-Funded Warrant.8-KFebruary 10, 2025001-15543
4.8Form of Private Warrant.8-KFebruary 10, 2025001-15543
4.9Form of Series C Warrant.8-KDecember 16, 2024001-15543
4.10Form of Series D Warrant.8-KDecember 16, 2024001-15543
4.11Form of Series B Warrant.8-KJune 21, 2024001-15543
4.12Form of February 1, 2024 Private Warrant.8-KFebruary 1, 2024001-15543
4.13Form of February 1, 2024 Placement Agent Warrant.8-KFebruary 1, 2024001-15543
4.14Form of January 24, 2024 Amendment to the Placement Agent Warrants issued on November 2, 2022 and October 24, 2023.10-QFebruary 14, 2024001-15543
4.15Form of January 24, 2024 Amendment to the Private Warrants issued to the Investor of November 2, 2022 and October 24, 2023.10-QFebruary 14, 2024001-15543
4.16Form of October 24, 2023 Private Warrant.8-KOctober 24, 2023001-15543
4.17Form of October 24, 2023 Placement Agent Warrant.8-KOctober 24, 2023001-15543
4.18Form of October 24, 2023 Pre-Funded Warrant.8-KOctober 24, 2023001-15543
4.19Form of Common Stock Purchase Warrant.10-QMay 16, 2022001-15543
4.20Form of Common Stock Purchase Warrant.10-QMay 16, 2022001-15543
4.21Form of Pre-Funded Warrant.8-KNovember 2, 2022001-15543
4.22Form of Common Warrant.8-KNovember 2, 2022001-15543
4.23For of Placement Agent Warrant.8-KNovember 2, 2022001-15543
4.24Form of Series A 2012 Warrant.8-KJuly 6, 2012001-15543
4.25Form of Series B 2012 Warrant.8-KJuly 6, 2012001-15543
Exhibit Number · Description · Filed Herewith · Form · Filing Date · SEC File No.
4.26Form of Series C 2014 Common Stock Purchase Warrant.8-KDecember 30, 2014001-15543
4.27Form of Series D 2014 Common Stock Purchase Warrant.8-KDecember 30, 2014001-15543
4.28Form of Series E 2015 Common Stock Purchase Warrant.8-KJuly 7, 2015001-15543
4.29Form of Series F 2015 Common Stock Purchase Warrant.8-KJuly 7, 2015001-15543
4.30Form of Series G 2015 Common Stock Purchase Warrant.8-KJuly 7, 2015001-15543
4.31Form of Series H 2016 Common Stock Purchase Warrant.8-KAugust 2, 2016001-15543
4.32Form of Series I 2016 Common Stock Purchase Warrant.8-KAugust 2, 2016001-15543
4.33Form of Series J 2016 Common Stock Purchase Warrant.8-KDecember 1, 2016001-15543
4.34Description of Securities10-KSeptember 12, 2019001-15543
10.1†1996 Stock Option Plan, as amended.10-KSeptember 28, 2009001-15543
10.2†Form of Option Certificate (Incentive Option) Under the 2005 Stock Plan.8-KSeptember 21, 2011001-15543
10.3†Form of Incentive Stock Option Under the 2005 Stock Plan.8-KSeptember 21, 2011001-15543
10.4†Form of Opinion Certificate (Non-Qualified Opinion) Under the 2005 Stock Plan.8-KSeptember 21, 2011001-15543
10.5†Form of Non-Qualified Stock Option Agreement Under the 2005 Stock Plan.8-KSeptember 21, 2011001-15543
10.6†2007 Change in Control Severance Plan.10-QFebruary 8, 2008001-15543
10.7†2005 Stock Plan, as amended.10-QMay 15, 2009001-15543
10.8†Form of Executive Officer Option Certificate.10-QMay 14, 2008001-15543
10.9†Form of Amended Restricted Stock Unit Agreement.10-QMay 14, 2008001-15543
10.10†Form of Amended Option Certificate (Incentive Option) Under the 2005 Stock Plan.10-QMay 14, 2008001-15543
10.11†2011 Stock Incentive Plan, as amended, restated and adopted by the stockholders on June 20, 2023.10-KSeptember 30, 2024001-15543
10.12†Form of Restricted Share Unit Agreement Under the 2011 Stock Incentive Plan.10-QMay 13, 2011001-15543
10.13†Form of Nonqualified Stock Option Agreement under the 2011 Stock Incentive Plan.10-QMay 13, 2011001-15543
10.14†Form of Incentive Stock Option Agreement under the 2011 Stock Incentive Plan.10-QMay 13, 2011001-15543
10.15†Form of Restricted Share Unit Agreement under the 2011 Stock Incentive Plan.8-KDecember 11, 2015001-15543
10.16†Form of Performance-Based Restricted Share Unit Agreement under the 2011 Stock Incentive Plan.8-KDecember 11, 2015001-15543
10.17†Form of Restricted Share Unit Agreement for Non-Employee Directors under the 2011 Stock Incentive Plan.8-KDecember 11, 2015001-15543
10.18†Amended form of Restricted Share Unit Agreement under the 2011 Stock Incentive Plan.10-QFebruary 12, 2016001-15543
10.19†Amended form of Performance-Based Restricted Share Unit Agreement under the 2011 Stock Incentive Plan.10-QFebruary 12, 2016001-15543
10.20†Amended form of Restricted Share Unit Agreement for Non-Employee Directors under the 2011 Stock Incentive Plan.10-QFebruary 12, 2016001-15543
10.21Form of Indenture.S-3August 17, 2018333-226905
10.22Amended and Restated Venture Loan and Security Agreement, dated July 2, 2015, by and between Palatin Technologies, Inc. and Horizon Technology Finance Corporation, Fortress Credit Co LLC, Horizon Credit II LLC and Fortress Credit Opportunities V CLO Limited.8-KJuly 7, 2015001-15543
10.23††Termination and Release Agreement dated September 29, 2020, by and between Catalent Belgium S.A. and Palatin Technologies, Inc.10-QNovember 16, 2020001-15543
10.24††Commercial Supply Agreement dated September 29, 2020, by and between Catalent Belgium S.A. and Palatin Technologies, Inc.10-QNovember 16, 2020001-15543
10.25††License Agreement, dated January 8, 2017, by and between AMAG Pharmaceuticals, Inc. and Palatin Technologies, Inc.10-QFebruary 10, 2017001-15543
10.26††License Agreement, dated September 6, 2017, by and between Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. and Palatin Technologies, Inc.10-QNovember 13, 2017001-15543
10.27†Employment Agreement, effective as of July 1, 2022, between Carl Spana and Palatin Technologies, Inc.8-KJune 24, 2022001-15543
10.28†Employment Agreement, effective as of July 1, 2022, between Stephen T. Wills and Palatin Technologies, Inc.8-KJune 24, 2022001-15543
10.29Termination Agreement between Palatin Technologies, Inc. And AMAG Pharmaceuticals, Inc., dated July 24, 2020.8-KJuly 27, 2020001-15543
10.30†††Manufacturing Services Agreement, dated as of June 1, 2019, by and between Palatin Technologies, Inc. (as assignee from AMAG Pharmaceuticals, Inc.) and Lonza Ltd.10-KSeptember 25, 2020001-15543
Exhibit NumberDescriptionFiled HerewithFormFiling DateSEC File No.
10.31†††Supply Agreement, dated as of December 20, 2018, by and between Palatin Technologies, Inc. (as assignee from AMAG Pharmaceuticals, Inc.) and Ypsomed AG.10-KSeptember 25, 2020001-15543
10.32Equity Distribution Agreement, dated April 12, 2023, between Palatin Technologies, Inc. and Canaccord Genuity LLC.8-KApril 12, 2023001-15543
10.33Form of Securities Purchase Agreement, dated October 20, 2023, between the Company and the Purchasers named therein.8-KOctober 24, 2023001-15543
10.34Asset Purchase Agreement entered into December 19, 2023, between the Company and Cosette Pharmaceuticals, Inc.10-QFebruary 14, 2024001-15543
10.35Form of Securities Purchase Agreement, dated January 29, 2024, between the Company and the Purchasers named therein.8-KFebruary 1, 2024001-15543
10.36Inducement Letter, dated June 20, 2024.8-KJune 21, 2024001-15543
19Palatin Technologies, Inc. Insider Trading and Securities Law Compliance Policy.10-KSeptember 30, 2024001-15543
21Subsidiary of Palatin Technologies, Inc.X
23Consent of KPMG LLP.X
31.1Certification of Chief Executive Officer.X
31.2Certification of Chief Financial Officer.X
32.1§Certification of principal executive officer pursuant to U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.X
32.2§Certification of principal financial officer pursuant to U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.X
97Palatin Technologies, Inc. Compensation Recovery Policy (Clawback Policy).10-KSeptember 30, 2024
101.INSInline XBRL Instance Document.X
101.SCHInline XBRL Taxonomy Extension Schema Document.X
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.X
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.X
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.X
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.X
104Cover Page Interactive Data File (Formatted as Inline XBRL and contained in Exhibit 101).X

† Management contract or compensatory plan or arrangement.

†† Confidential treatment granted as to certain portions of the exhibit, which portions are omitted and filed separately with the SEC.

††† Portions of the exhibit are omitted pursuant to Regulation S-K Item 601(b)(10). Palatin agrees to furnish to the U.S. Securities and Exchange Commission a copy of any omitted schedule and/or exhibit upon request. The confidential portions of this exhibit were omitted by means of marking such portions with asterisks because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.

§ In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release Nos. 33-8238 and 34-47986, Final Rule: Management’s Reports on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished in Exhibit 32.1 and 32.2 hereto is deemed to accompany this Annual Report on Form 10-K and will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates them by reference.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.